Person

Michael R. McDonnell

Director, Moderna

Current S&P 500 boards
2
Current roles
2
Open-market buys
$0
Open-market sales
$3.1M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • BIIB
    Biogen
    EVP, Chief Financial Officer
    Aug 2020 – last filing Feb 2025
  • IQV
    IQVIA
    EVP and CFO
    2016 or earlier – last filing Jul 2020

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jan 2, 2020IQVSale12,000$155.07$1.9M
Dec 3, 2018IQVSale9,500$128.35$1.2M

SEC reporting-owner ID (CIK) 1121897 · all filings on EDGAR